Sisram Medical Ltd. (HK:1696) has released an update.
Sisram Medical Ltd has announced the introduction of Revanesse, a versatile dermal filler line, to the U.K. market through a strategic partnership with Prollenium, a Canadian manufacturer. The company expects this expansion to complement its existing product offerings and strengthen its position in the U.K. and global markets, potentially enhancing its revenue growth. Investors are reminded to trade cautiously with the company’s securities.
For further insights into HK:1696 stock, check out TipRanks’ Stock Analysis page.